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Abstract: We describe a clinical case of Cornelia de Lange syndrome (CDLs) diagnosed prenatally and present the 
pathological and cytogenetic findings.  
Our observations from the pathological analysis, including upper limb hemimelia, short upper limbs, microretrognathia, 
and hypospadias, were compatible with CDLs. The cytogenetic study revealed a normal karyotype with a series of 
polymorphisms without clinical relevance according to current studies and a heterozygous duplication encoding a 
nonsense mutation in the NIPBL gene that resulted in a truncated protein lacking 38% of its amino acids. This 
duplication has not been previously described in any database or literature available to date. 
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INTRODUCTION 
Cornelia de Lange syndrome (CDLs) is a multiple 
malformation congenital disorder [1] that affects the 
cognitive and physical development of afflicted infants. 
CDLs is characterised by facial alterations associated 
with late pre- and postnatal development, varying 
degrees of intellectual disability, and in some cases 
abnormal upper limbs [2]. Many of the clinical features 
are apparent at birth or at an early age. The exact 
incidence of this syndrome is unknown, but it is 
estimated to occur with a frequency of 1:10,000-30,000 
with no differences between genders. 
In 1933, two unrelated cases of infants bearing 
similar traits were reported by the Dutch paediatrician 
Cornelia de Lange who is recognised as having 
formally described the features comprising this 
syndrome for the first time. It is also known as 
Brachmann-de Lange syndrome because W. 
Brachmann [3] described similar findings in another 
patient in 1916. CDLs is a congenital syndrome. 
Although patients do not always show all of the 
features of this disorder, the presence of sufficient 
clinical characteristics usually enables a correct 
diagnosis. 
Concerning the genetics of the syndrome, most 
cases are the result of spontaneous mutations. 
However, the affected genes causing the disease can 
 
 
*Address correspondence to this author at the José Claudio Maañón Di Leo. 
MD. Obstetrics and Gynaecology area, Hospital Costa Del Sol, A7 Km 187, 
Marbella, Spain; Tel: 0034 620815042. ORCID: 0000-0001-7761-0518;  
E-mail: jcm@hcs.es 
be inherited from both progenitors and is what makes 
this syndrome an autosomal dominant disease. 
Mutations in the NIPBL, SMC1A, and SMC3 genes 
have been associated with CDLs. 
A mutated NIPBL gene (Cohesin Loading Factor, 
locus 5p13-14) was discovered through research at the 
Children’s Hospital of Philadelphia in 2004; with 47 
exons, this gene presents isoforms with 2804 or 2697 
amino acids and has been associated with 
approximately half of the CDLs cases. In 2006, Italian 
scientists reported a second gene (SMC1A, locus 
Xp11.2) linked with this syndrome. The heterogeneity 
of this syndrome is associated with mutations in other 
genes, including SMC3, RAD21, and HDAC8 [4-7]. 
CDLs cases associated with SMC1A mutations 
exhibit an X-linked inheritance pattern [8]. Other 
studies concerning X-linked CDLs indicate that a single 
copy of the mutated gene per cell is sufficient to cause 
this disease. Unlike most X-linked conditions in which 
men are more frequently afflicted or experience more 
severe symptoms, X-linked CDLs seems to affect both 
genders equally. 
Mutations in these genes related to the cohesin 
complex are responsible for compromised chromo- 
some segregation during cell division [9, 10]. 
Most cases are the result of new genetic mutations 
occurring in individuals without a familial history of 
CDLs. 
Currently, approximately 50% of patients with a 
compatible CDLs phenotype do not show mutations in 
any of the known associated genes. 
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This study describes a case of CDLs associated 
with a mutation in the NIPBL gene that has not 
previously been described or linked with CDLs. 
CASE PRESENTATION 
A 31-year-old female with two previous 
pregnancies, the first of which was from a different 
partner, presented to the clinic for a routine first 
trimester pregnancy evaluation. No pathological signs 
were detected in the ultrasound, the serological test 
was normal, and the malformation screening was 
assessed as low risk. In the following visit, the 20-week 
ultrasound showed a 19-week-old male foetus with 
clear morphological alterations [i.e., affected distal 
upper limbs (right upper limb: short humerus below the 
5th percentile with rudimentary forearm and hand; left 
upper limb: short humerus below the 5th percentile with 
forearm agenesis and rudimentary hand with 
ectrodactyly) and abnormal profile (microretrognathia, 
prominent upper lip and prefrontal oedema, discreet 
pericardial haemorrhage, and chordee suggesting 
hypospadias)] (Figure 1). These observations were 
confirmed in subsequent examinations. 
Once a diagnosis of skeletal abnormalities (bilateral 
hemimelia and microretrognathia) was made, the 
patient was informed of the neonatal prognosis. After a 
second opinion confirming the ultrasound findings was 
obtained, the patient opted for a legal termination of 
pregnancy four days after the initial diagnosis. A 
cytogenetic study on amniotic fluid samples obtained 
by amniocentesis was performed prior to pregnancy 
termination. 
DIFFERENTIAL DIAGNOSIS 
The foetus and placenta were analysed by the 
Department of Anatomy and Pathology of our hospital. 
The samples obtained for the cytogenetic study were 
sent to our reference laboratory. 
For the genetic study of CDLs, a comparative 
genomic hybridisation analysis (CGH) was conducted 
as follows. Genomic DNA was extracted from amniotic 
fluid samples using a MagNA Pure instrument (Roche), 
followed by specific amplification of 48 fragments in the 
coding and flanking intronic sequences of the NIPBL 
gene (NM_133433.2 GenBank); exons 21, 33, and 41 
were not included in the analysis. The PCR amplicons 
were sequenced in an ABI 3130 Genetic Analyzer 
(Applied Biosystems). The sequences obtained were 
analysed using the SeqScape v2.5 software and 
compared against multiple databases. 
The pathological study results showed a 284 g 
foetus with a crown-rump length of 16 cm and foot 
length of 3 cm. The foetus had bilateral palpebral 
oedema, severe retrognathia, phocomelia-type 
malformation of the upper limbs with rudimentary 
 
Figure 1: Facial alterations observed in the 20-week ultrasound. 
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forearms and hands, and hypospadias. No 
macroscopically evident internal malformations were 
observed. The trivascular umbilical cord was 4 cm in 
length. The placenta was normal. The final pathology 
report concluded that these foetal alterations could be 
grouped within cohesinopathies, which include CDLs. 
The cytogenetic study at a 400-band resolution did 
not show any chromosomal anomaly. A male 
chromosome formula (46, XY) was observed. 
A comparative genomic hybridisation analysis 
(Array CGH 60K, directed at the genomic analysis of 
NIPBL-related CDLs) (Figure 2) was performed using 
amniotic fluid samples. The sequencing results 
revealed the heterozygous duplication c.5249dupA, 
which encoded a stop codon at p.Tyr1750Term 
(Y1750X). This duplication results in a truncated 
protein lacking 38% of the amino acids. At the time of 
writing this manuscript, this duplication has not been 
described elsewhere. These results do not exclude 
variations in the NIPBL gene, such as mutations 
outside the analysed region or mutations undetectable 
by DNA sequencing. 
Gene NIPBL (OMIM: 608667) and locus 5p13.2 
(OMIM phenotype: 122470) were analysed. The 
mutations exhibited autosomal dominant inheritance. 
Additionally, a series of clinically irrelevant 
polymorphisms, according to our reference laboratory, 
were found. 
DISCUSSION 
We describe a new mutation in the NIPBL gene 
found during the study of a case of CDLs. 
Genetic mutations in the NIPBL gene have been 
identified in more than half of the afflicted population, 
whereas mutations in other genes involved are less 
frequent [11]. The proteins produced by these genes 
play important roles in foetal development. Within the 
cells, these proteins assist in regulating the 
chromosome structure and organisation and are 
involved in DNA repair. These genes also regulate the 
activity of certain genes that participate in the 
development of the limbs, face, and other parts of the 
body. 
The NIPBL gene, which contains 47 exons and is 
188 kb in size, has at least 43 polymorphisms that are 
not associated with pathological phenotypes. This gene 
is located in 5p13-14 and exhibits high allelic 
heterogeneity (199 allelic variants in 246 patients 
associated with 65% of CDLs cases). 
To date, 144 different mutations affecting ~45% of 
patients have been reported. In our patient, we found a 
 
Figure 2: Karyogram using an array CGH. Blue represents gains (right side), and red represents losses (left side). 
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heterozygous duplication c.5249dupA encoding stop 
codon p.Tyr1750Term (Y1750X). These mutations 
result in a frameshift in 34.5% of cases, a missense 
mutation in 23.6% of cases, nonsense mutations (such 
as our clinical case) in 18.8% of cases, effects on 
splicing sequences in 16% of cases, and other effects 
in 6.2% of cases. 
The positions of these mutations within the gene 
showed a peculiar distribution. Point and missense 
mutations were concentrated towards the HEAT (helix-
turn-helix) repeat region in the C-terminus (43.3%), 
whereas the more severe nonsense mutations were 
more frequent towards the N-terminus. Curiously, the 
same phenotype is not always observed in patients 
with the same mutation, and occasionally, large 
phenotypic differences are found. Therefore, the 
existence of additional influencing factors (whether 
genetic or not) in the aetiology of this syndrome has 
been suggested. 
The NIPBL gene encodes a protein known as 
Nipped-B-Like, which has a long isoform composed of 
2804 amino acids and a short form composed of only 
2697 amino acids. The more severe phenotypes of this 
disease are linked with nonsense mutations. Nipped-B-
Like plays an important role in growth and development 
processes. During the prenatal stage, the protein is 
located in the developing limbs, cranial and facial 
bones, spinal column, heart, and other tissues [12]. 
This protein is also involved in chromosome migration 
during cell division and controls the interaction of the 
cohesin-DNA complex [13]. CDLs is characterised by a 
precocious separation of sister chromatids. In our case, 
the foetus showed severe retrognathia, phocomelia-
type malformation of the upper limbs with rudimentary 
forearms and hands, and hypospadias. Anatomic 
abnormalities in the brain and central nervous system 
specific to CDLs have been observed and were 
correlated with changes in MRI images [14]. 
The precise cause of CDLs is unknown in 
approximately 35% of cases. Researchers are seeking 
additional modifications in the NIPBL, SMC1A, and 
SMC3 genes as well as mutations in other genes that 
may be responsible for this condition. 
Therefore, CDLs is a heterogeneous genetic 
disorder, which explains the diversity in the expression 
of its clinical phenotype. 
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